Stopping GLP-1 treatment too soon can also lead to rebound weight gain or increased blood sugar levels
Both semaglutide (as Wegovy) and tirzepatide (as Zepbound) are specifically FDA-approved for weight management in people without diabetes who meet BMI criteria
Semaglutide slows gastric emptying, so anesthesia guidelines recommend stopping weekly GLP-1 medications at least 1 week before elective surgery to reduce aspiration risk
It is often combined with platinum-based chemotherapy regimens for the treatment of various malignancies ( A study found that low-dose QUE combined with PTX had more potent inhibitory effects on the proliferation, cell cycle, and migration of PC-3 prostate cancer cells than PTX alone, whereas this combination promoted apoptosis ( However, the oral administration of PTX remains problematic owing to its low oral bioavailability ( 3.0.Co;2-v 30 XavierCPLimaCFRohdeMPereira-WilsonC
Diabetes, obesity & metabolism , 27 Suppl 2 (Suppl 2), 6688.
The photo below is before and after 2 sessions.